1.
Type 2 diabetes
by Chatterjee, Sudesna, MD
The Lancet (British edition), 2017, Vol.389 (10085), p.2239-2251
2.
Diabetes mellitus: The linkage between oxidative stress, inflammation, hypercoagulability and vascular complications
by Domingueti, Caroline Pereira
Journal of diabetes and its complications, 2015, Vol.30 (4), p.738-745
3.
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
by Kautzky-Willer, Alexandra
Endocrine reviews, 2016-06, Vol.37 (3), p.278-316
4.
Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial
by Gæde, Peter
Diabetologia, 2016-08-16, Vol.59 (11), p.2298-2307
5.
The gut microbiome as a target for prevention and treatment of hyperglycaemia in type 2 diabetes: from current human evidence to future possibilities
by Brunkwall, Louise
Diabetologia, 2017-04-22, Vol.60 (6), p.943-951
6.
7.
Type 2 diabetes across generations: from pathophysiology to prevention and management
by Nolan, Christopher J, Assoc Prof
The Lancet (British edition), 2011, Vol.378 (9786), p.169-181
8.
The many faces of diabetes: a disease with increasing heterogeneity
by Tuomi, Tiinamaija, MD
The Lancet (British edition), 2014, Vol.383 (9922), p.1084-1094
9.
Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis
by Bellamy, Leanne, MBBS
The Lancet (British edition), 2009, Vol.373 (9677), p.1773-1779
10.
Periodontitis and diabetes: a two-way relationship
by Preshaw, P. M
Diabetologia, 2011-11-06, Vol.55 (1), p.21-31
11.
Molecular mechanisms of diabetic cardiomyopathy
by Bugger, Heiko
Diabetologia, 2014-01-30, Vol.57 (4), p.660-671
12.
Diabetes at the crossroads: relevance of disease classification to pathophysiology and treatment
by Leslie, R. David
Diabetologia, 2015-10-24, Vol.59 (1), p.13-20
13.
Precision diabetes: learning from monogenic diabetes
by Hattersley, Andrew T
Diabetologia, 2017-03-17, Vol.60 (5), p.769-777
14.
Lower circulating irisin is associated with type 2 diabetes mellitus
by Liu, Jian-Jun
Journal of diabetes and its complications, 2013, Vol.27 (4), p.365-369
15.
Metabolomics insights into early type 2 diabetes pathogenesis and detection in individuals with normal fasting glucose
by Merino, Jordi
Diabetologia, 2018-04-06, Vol.61 (6), p.1315-1324
16.
Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future
by Kahn, Steven E, Prof
The Lancet (British edition), 2014, Vol.383 (9922), p.1068-1083
17.
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
by le Roux, Carel W, Prof
The Lancet (British edition), 2017, Vol.389 (10077), p.1399-1409
18.
Diabetes in the older patient: heterogeneity requires individualisation of therapeutic strategies
by Schernthaner, Guntram
Diabetologia, 2018-02-07, Vol.61 (7), p.1503-1516
19.
Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug
by Wu, Hao
Nature Medicine, 2017-07, Vol.23 (7), p.850-858
20.
Whole grain and refined grain consumption and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis of cohort studies
by Aune, Dagfinn
European journal of epidemiology, 2013-01-01, Vol.28 (11), p.845-858
